Kidney Transplant Recipient Clinical Trial
The aim of this study is to evaluate the clinical usefulness of 64-slice multidetector coronary CT angiography (MDCTA) in renal transplant recipients who had no previous coronary artery disease (CAD). Primary endpoint is to assess the prevalence and severity of coronary artery disease in patients post-transplant 6 to 12 months. CAD can be diagnosed noninvasively with similar accuracy of coronary angiography using MDCTA. Early detection and intervention of CAD may provide survival benefit in renal transplant recipients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03697317 -
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
|
N/A | |
Completed |
NCT06011850 -
Investigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
|
||
Completed |
NCT00307125 -
Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
|
Phase 2 | |
Completed |
NCT01087190 -
Isoniazid (INH) Treatment Based on ELISPOT Assay
|
N/A | |
Completed |
NCT01093703 -
Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients
|
N/A | |
Recruiting |
NCT05975450 -
Subcutaneous Abatacept in Renal Transplant Recipients
|
Phase 1 | |
Completed |
NCT00189150 -
Pharmacokinetics of Mmf and Valganciclovir
|
Phase 4 | |
Active, not recruiting |
NCT05220397 -
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
|
Phase 3 |